STAT3 and metabolic dysfunction-associated steatohepatitis: A recent study found that in a NASH-HCC model (Wang et al., 2009) established by the administration of DEN to mice fed a HFD, GTE inhibited the signal transducer (gp130, tumor suppressor M) that promotes STAT3 activation (Stephens and Elks, 2017).